Other current appointments
- Chairman of the Board of Directors of Corium Therapeutics Inc., USA, since 2024
- Member of the Board of Directors of Amylyx Pharmaceuticals Inc., USA; Apnimed Inc., USA; Apellis Pharmaceuticals Inc., USA; and DalCor Inc., London, UK – four biotechnology companies
- Executive in Residence at Canaan Partners (venture capital)
Previous appointments and professional experience
- Member of the Board of Directors of Gelesis Inc., until 2023
- Member of the Board of Directors of Covetrus Inc., until 2022
- Member of the Board of Directors of ResTORbio Inc., until 2020
- Member of the Board of Directors of AMAG Pharmaceuticals Inc., until 2020
- Member of the Board of Directors of the Pharmaceutical Research and Manufacturers of America (PhRMA)
- Chairman of the Board and CEO of Boehringer Ingelheim USA, as well as Country Managing Director for the USA, 2012–2018; previously Head of Global Marketing for Human Pharmaceuticals, Germany, 2008–2011, and Head of Human Pharmaceuticals, USA, 2003–2008
- Various roles at Merck & Co., Inc., 1994–2003, and at Abbott Laboratories Inc., 1987–1993
- Chair of the National Pharmaceutical Council (NPC)
Education
- Carnegie Mellon University, Pittsburgh, MBA, 1985–1987
- University of Brussels, chemical engineering
